Created at	Source	Raw Value	Validated value
Aug. 2, 2022, 4:30 p.m.	usa	Reactogenicity of a booster dose of COVID-19 vaccine in patients on anti-CD-20 mAb.;Safety of a booster dose of COVID-19 vaccine in patients on anti-CD-20 mAb.	Reactogenicity of a booster dose of COVID-19 vaccine in patients on anti-CD-20 mAb.;Safety of a booster dose of COVID-19 vaccine in patients on anti-CD-20 mAb.
Feb. 12, 2022, 3:30 p.m.	usa	Safety and reactogenicity of a fourth dose of COVID-19 vaccine in patients on anti-CD-20 mAb.;Safety and reactogenicity of a fourth dose of COVID-19 vaccine in patients on anti-CD-20 mAb.;Safety and reactogenicity of a fourth dose of COVID-19 vaccine in patients on anti-CD-20 mAb.	Safety and reactogenicity of a fourth dose of COVID-19 vaccine in patients on anti-CD-20 mAb.;Safety and reactogenicity of a fourth dose of COVID-19 vaccine in patients on anti-CD-20 mAb.;Safety and reactogenicity of a fourth dose of COVID-19 vaccine in patients on anti-CD-20 mAb.